Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Use of a commercial ion chamber detector array for the measurement of high spatial-resolution photon beam profiles.

Karimnia V, Belley MD, Rodgers R, Price M.

J Appl Clin Med Phys. 2018 Nov;19(6):323-331. doi: 10.1002/acm2.12466. Epub 2018 Oct 4.

2.

Equivalency of beam scan data collection using a 1D tank and automated couch movements to traditional 3D tank measurements.

Knutson NC, Schmidt MC, Belley MD, Nguyen N, Price M, Mutic S, Sajo E, Li HH.

J Appl Clin Med Phys. 2018 Nov;19(6):60-67. doi: 10.1002/acm2.12444. Epub 2018 Sep 6.

3.

Real-time dose-rate monitoring with gynecologic brachytherapy: Results of an initial clinical trial.

Belley MD, Craciunescu O, Chang Z, Langloss BW, Stanton IN, Yoshizumi TT, Therien MJ, Chino JP.

Brachytherapy. 2018 Nov - Dec;17(6):1023-1029. doi: 10.1016/j.brachy.2018.07.014. Epub 2018 Aug 24.

PMID:
30150015
4.

Technical Note: Direct measurement of continuous TMR data with a 1D tank and automated couch movements.

Knutson NC, Schmidt MC, Belley MD, Nguyen NB, Li HH, Sajo E, Price MJ.

Med Phys. 2017 Jul;44(7):3861-3865. doi: 10.1002/mp.12289. Epub 2017 May 24.

PMID:
28429391
5.

Activated β2 Integrins Restrict Neutrophil Recruitment during Murine Acute Pseudomonal Pneumonia.

Wilson ZS, Ahn LB, Serratelli WS, Belley MD, Lomas-Neira J, Sen M, Lefort CT.

Am J Respir Cell Mol Biol. 2017 May;56(5):620-627. doi: 10.1165/rcmb.2016-0215OC.

6.

Microdosimetric and Biological Effects of Photon Irradiation at Different Energies in Bone Marrow.

Belley MD, Ashcraft KA, Lee CT, Cornwall-Brady MR, Chen JJ, Gunasingha R, Burkhart M, Dewhirst M, Yoshizumi TT, Down JD.

Radiat Res. 2015 Oct;184(4):378-91. doi: 10.1667/RR14095.1. Epub 2015 Sep 24.

PMID:
26401594
7.

Fiber-optic detector for real time dosimetry of a micro-planar x-ray beam.

Belley MD, Stanton IN, Hadsell M, Ger R, Langloss BW, Lu J, Zhou O, Chang SX, Therien MJ, Yoshizumi TT.

Med Phys. 2015 Apr;42(4):1966-72. doi: 10.1118/1.4915078.

8.

Investigating the accuracy of microstereotactic-body-radiotherapy utilizing anatomically accurate 3D printed rodent-morphic dosimeters.

Bache ST, Juang T, Belley MD, Koontz BF, Adamovics J, Yoshizumi TT, Kirsch DG, Oldham M.

Med Phys. 2015 Feb;42(2):846-55. doi: 10.1118/1.4905489.

9.

Verification of a novel method for tube voltage constancy measurement of orthovoltage x-ray irradiators.

Wang C, Belley MD, Chao NJ, Dewhirst MW, Yoshizumi T.

Med Phys. 2014 Aug;41(8):084101. doi: 10.1118/1.4889778.

10.
11.

Europium- and lithium-doped yttrium oxide nanocrystals that provide a linear emissive response with X-ray radiation exposure.

Stanton IN, Belley MD, Nguyen G, Rodrigues A, Li Y, Kirsch DG, Yoshizumi TT, Therien MJ.

Nanoscale. 2014 May 21;6(10):5284-8. doi: 10.1039/c4nr00497c.

12.

Accuracy of effective dose estimation in personal dosimetry: a comparison between single-badge and double-badge methods and the MOSFET method.

Januzis N, Belley MD, Nguyen G, Toncheva G, Lowry C, Miller MJ, Smith TP, Yoshizumi TT.

Health Phys. 2014 May;106(5):551-7. doi: 10.1097/HP.0b013e3182a82d3b.

PMID:
24670903
13.

Toward an organ based dose prescription method for the improved accuracy of murine dose in orthovoltage x-ray irradiators.

Belley MD, Wang C, Nguyen G, Gunasingha R, Chao NJ, Chen BJ, Dewhirst MW, Yoshizumi TT.

Med Phys. 2014 Mar;41(3):034101. doi: 10.1118/1.4864237.

14.

Seebeck and figure of merit enhancement in nanostructured antimony telluride by antisite defect suppression through sulfur doping.

Mehta RJ, Zhang Y, Zhu H, Parker DS, Belley M, Singh DJ, Ramprasad R, Borca-Tasciuc T, Ramanath G.

Nano Lett. 2012 Sep 12;12(9):4523-9. doi: 10.1021/nl301639t. Epub 2012 Aug 21.

PMID:
22891784
15.

Synthesis and SAR of pyrimidine-based, non-nucleotide P2Y14 receptor antagonists.

Guay D, Beaulieu C, Belley M, Crane SN, DeLuca J, Gareau Y, Hamel M, Henault M, Hyjazie H, Kargman S, Chan CC, Xu L, Gordon R, Li L, Mamane Y, Morin N, Mancini J, Thérien M, Tranmer G, Truong VL, Wang Z, Black WC.

Bioorg Med Chem Lett. 2011 May 15;21(10):2832-5. doi: 10.1016/j.bmcl.2011.03.084. Epub 2011 Mar 30.

PMID:
21507642
16.

The identification of 4,7-disubstituted naphthoic acid derivatives as UDP-competitive antagonists of P2Y14.

Gauthier JY, Belley M, Deschênes D, Fournier JF, Gagné S, Gareau Y, Hamel M, Hénault M, Hyjazie H, Kargman S, Lavallée G, Levesque JF, Li L, Mamane Y, Mancini J, Morin N, Mulrooney E, Robichaud J, Thérien M, Tranmer G, Wang Z, Wu J, Black WC.

Bioorg Med Chem Lett. 2011 May 15;21(10):2836-9. doi: 10.1016/j.bmcl.2011.03.081. Epub 2011 Mar 31.

PMID:
21507640
17.

Remote electronic control in the regioselective reduction of succinimides: a practical, scalable synthesis of Ep4 antagonist MF-310.

Molinaro C, Gauvreau D, Hughes G, Lau S, Lauzon S, Angelaud R, O'Shea PD, Janey J, Palucki M, Hoerrner SR, Raab CE, Sidler RR, Belley M, Han Y.

J Org Chem. 2009 Sep 4;74(17):6863-6. doi: 10.1021/jo901267x.

PMID:
19663395
18.

Discovery of [(3-bromo-7-cyano-2-naphthyl)(difluoro)methyl]phosphonic acid, a potent and orally active small molecule PTP1B inhibitor.

Han Y, Belley M, Bayly CI, Colucci J, Dufresne C, Giroux A, Lau CK, Leblanc Y, McKay D, Therien M, Wilson MC, Skorey K, Chan CC, Scapin G, Kennedy BP.

Bioorg Med Chem Lett. 2008 Jun 1;18(11):3200-5. doi: 10.1016/j.bmcl.2008.04.064. Epub 2008 Apr 29.

PMID:
18477508
19.

Structure-activity relationships and pharmacokinetic parameters of quinoline acylsulfonamides as potent and selective antagonists of the EP(4) receptor.

Burch JD, Belley M, Fortin R, Deschênes D, Girard M, Colucci J, Farand J, Therien AG, Mathieu MC, Denis D, Vigneault E, Lévesque JF, Gagné S, Wrona M, Xu D, Clark P, Rowland S, Han Y.

Bioorg Med Chem Lett. 2008 Mar 15;18(6):2048-54. doi: 10.1016/j.bmcl.2008.01.103. Epub 2008 Jan 31.

PMID:
18291643
20.

Comparison between two classes of selective EP(3) antagonists and their biological activities.

Belley M, Chan CC, Gareau Y, Gallant M, Juteau H, Houde K, Lachance N, Labelle M, Sawyer N, Tremblay N, Lamontagne S, Carrière MC, Denis D, Greig GM, Slipetz D, Gordon R, Chauret N, Li C, Zamboni RJ, Metters KM.

Bioorg Med Chem Lett. 2006 Nov 1;16(21):5639-42. Epub 2006 Aug 22.

PMID:
16931013
21.

Comparison of the antinociceptive profiles of gabapentin and 3-methylgabapentin in rat models of acute and persistent pain: implications for mechanism of action.

Urban MO, Ren K, Park KT, Campbell B, Anker N, Stearns B, Aiyar J, Belley M, Cohen C, Bristow L.

J Pharmacol Exp Ther. 2005 Jun;313(3):1209-16. Epub 2005 Feb 25.

PMID:
15734900
22.

Structure-activity relationship studies on ortho-substituted cinnamic acids, a new class of selective EP(3) antagonists.

Belley M, Gallant M, Roy B, Houde K, Lachance N, Labelle M, Trimble LA, Chauret N, Li C, Sawyer N, Tremblay N, Lamontagne S, Carrière MC, Denis D, Greig GM, Slipetz D, Metters KM, Gordon R, Chan CC, Zamboni RJ.

Bioorg Med Chem Lett. 2005 Feb 1;15(3):527-30.

PMID:
15664806
23.

Structure-activity relationship of triaryl propionic acid analogues on the human EP3 prostanoid receptor.

Gallant M, Belley M, Carrière MC, Chateauneuf A, Denis D, Lachance N, Lamontagne S, Metters KM, Sawyer N, Slipetz D, Truchon JF, Labelle M.

Bioorg Med Chem Lett. 2003 Nov 3;13(21):3813-6.

PMID:
14552786
24.

Gamma-aminobutyric acid type B receptors with specific heterodimer composition and postsynaptic actions in hippocampal neurons are targets of anticonvulsant gabapentin action.

Ng GY, Bertrand S, Sullivan R, Ethier N, Wang J, Yergey J, Belley M, Trimble L, Bateman K, Alder L, Smith A, McKernan R, Metters K, O'Neill GP, Lacaille JC, Hébert TE.

Mol Pharmacol. 2001 Jan;59(1):144-52.

PMID:
11125035
25.

Coexpression of full-length gamma-aminobutyric acid(B) (GABA(B)) receptors with truncated receptors and metabotropic glutamate receptor 4 supports the GABA(B) heterodimer as the functional receptor.

Sullivan R, Chateauneuf A, Coulombe N, Kolakowski LF Jr, Johnson MP, Hebert TE, Ethier N, Belley M, Metters K, Abramovitz M, O'Neill GP, Ng GY.

J Pharmacol Exp Ther. 2000 May;293(2):460-7.

PMID:
10773016
26.

Synthesis of the nanomolar photoaffinity GABA(B) receptor ligand CGP 71872 reveals diversity in the tissue distribution of GABA(B) receptor forms.

Belley M, Sullivan R, Reeves A, Evans J, O'Neill G, Ng GY.

Bioorg Med Chem. 1999 Dec;7(12):2697-704.

PMID:
10658574
27.

The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs.

Abramovitz M, Adam M, Boie Y, Carrière M, Denis D, Godbout C, Lamontagne S, Rochette C, Sawyer N, Tremblay NM, Belley M, Gallant M, Dufresne C, Gareau Y, Ruel R, Juteau H, Labelle M, Ouimet N, Metters KM.

Biochim Biophys Acta. 2000 Jan 17;1483(2):285-93.

PMID:
10634944
28.

Differential effect of a selective cyclooxygenase-2 inhibitor versus indomethacin on renal blood flow in conscious volume-depleted dogs.

Black SC, Brideau C, Cirino M, Belley M, Bosquet J, Chan CC, Rodger IW.

J Cardiovasc Pharmacol. 1998 Nov;32(5):686-94.

PMID:
9821840
29.

Structural characterization of the covalent attachment of leukotriene A3 to leukotriene A4 hydrolase.

Mancini JA, Waugh RJ, Thompson JA, Evans JF, Belley M, Zamboni R, Murphy RC.

Arch Biochem Biophys. 1998 Jun 1;354(1):117-24.

PMID:
9633605
30.

From indomethacin to a selective COX-2 inhibitor. Development of indolalkanoic acids as potent and selective cyclooxygenase-2 inhibitors.

Lau CK, Black WC, Belley M, Chan C, Charleson S, Denis D, Gauthier JY, Gordon R, Guay D, Hamel P, Kargman S, Leblanc Y, Mancini J, Ouellet M, Percival D, Prasit P, Roy P, Skorey K, Tagari P, Vickers P, Wong E.

Adv Exp Med Biol. 1997;407:73-8. No abstract available.

PMID:
9321934
31.

Pharmacology of montelukast sodium (Singulair), a potent and selective leukotriene D4 receptor antagonist.

Jones TR, Labelle M, Belley M, Champion E, Charette L, Evans J, Ford-Hutchinson AW, Gauthier JY, Lord A, Masson P, et al.

Can J Physiol Pharmacol. 1995 Feb;73(2):191-201. Erratum in: Can J Physiol Pharmacol 1995 Jun;73(6):747.

PMID:
7621356
32.

A new class of leukotriene biosynthesis inhibitor: the development of MK-0591.

Prasit P, Belley M, Blouin M, Brideau C, Chan C, Charleson S, Evans JF, Frenette R, Gauthier JY, Guay J, et al.

J Lipid Mediat. 1993 Mar-Apr;6(1-3):239-44.

PMID:
8357985
34.

Pharmacology of the leukotriene antagonist verlukast: the (R)-enantiomer of MK-571.

Jones TR, Zamboni R, Belley M, Champion E, Charette L, Ford-Hutchinson AW, Gauthier JY, Leger S, Lord A, Masson P, et al.

Can J Physiol Pharmacol. 1991 Dec;69(12):1847-54.

PMID:
1666333
35.

Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist.

Jones TR, Zamboni R, Belley M, Champion E, Charette L, Ford-Hutchinson AW, Frenette R, Gauthier JY, Leger S, Masson P, et al.

Can J Physiol Pharmacol. 1989 Jan;67(1):17-28.

PMID:
2540892
36.

[Chylous ascites with pre-aortico-cava lymphngiectasis. Lympho-venous anastomosis with genital veins].

Michotey G, Mercier C, Assadourian R, Belley M.

Arch Fr Mal App Dig. 1970 Apr-Mar;59(4):271-2. French. No abstract available.

PMID:
5419217

Supplemental Content

Loading ...
Support Center